No abstract available
MeSH terms
-
Adult
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use*
-
Follow-Up Studies
-
Hepatitis C, Chronic / complications*
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / therapeutic use*
-
Interferons / therapeutic use*
-
Male
-
Methylprednisolone / administration & dosage
-
Methylprednisolone / therapeutic use*
-
Polyethylene Glycols / administration & dosage
-
Polyethylene Glycols / therapeutic use*
-
Recombinant Proteins
-
Ribavirin / administration & dosage
-
Ribavirin / therapeutic use*
-
Sarcoidosis, Pulmonary / complications*
-
Sarcoidosis, Pulmonary / drug therapy*
-
Time Factors
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
Interferons
-
peginterferon alfa-2a
-
Methylprednisolone